Cargando…
Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria
ANP is mainly synthesized by the atria, and upon excretion, it serves two primary purposes: vasodilation and increasing the renal excretion of sodium and water. The understanding of ANP’s role in cardiac systems has improved considerably in recent decades. This review focuses on several studies demo...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095038/ https://www.ncbi.nlm.nih.gov/pubmed/37047444 http://dx.doi.org/10.3390/ijms24076470 |
_version_ | 1785023985306566656 |
---|---|
author | Rahbar Kouibaran, Farzad Sabatino, Mario Barozzi, Chiara Diemberger, Igor |
author_facet | Rahbar Kouibaran, Farzad Sabatino, Mario Barozzi, Chiara Diemberger, Igor |
author_sort | Rahbar Kouibaran, Farzad |
collection | PubMed |
description | ANP is mainly synthesized by the atria, and upon excretion, it serves two primary purposes: vasodilation and increasing the renal excretion of sodium and water. The understanding of ANP’s role in cardiac systems has improved considerably in recent decades. This review focuses on several studies demonstrating the importance of analyzing the regulations between the endocrine and mechanical function of the heart and emphasizes the effect of ANP, as the primary hormone of the atria, on atrial fibrillation (AF) and related diseases. The review first discusses the available data on the diagnostic and therapeutic applications of ANP and then explains effect of ANP on heart failure (HF) and atrial fibrillation (AF) and vice versa, where tracking ANP levels could lead to understanding the pathophysiological mechanisms operating in these diseases. Second, it focuses on conventional treatments for AF, such as cardioversion and catheter ablation, and their effects on cardiac endocrine and mechanical function. Finally, it provides a point of view about the delayed recovery of cardiac mechanical and endocrine function after cardioversion, which can contribute to the occurrence of acute heart failure, and the potential impact of restoration of the sinus rhythm by extensive ablation or surgery in losing ANP-producing sites. Overall, ANP plays a key role in heart failure through its effects on vasodilation and natriuresis, leading to a decrease in the activity of the renin-angiotensin-aldosterone system, but it is crucial to understand the intimate role of ANP in HF and AF to improve their diagnosis and personalizing the patients’ treatment. |
format | Online Article Text |
id | pubmed-10095038 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100950382023-04-13 Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria Rahbar Kouibaran, Farzad Sabatino, Mario Barozzi, Chiara Diemberger, Igor Int J Mol Sci Review ANP is mainly synthesized by the atria, and upon excretion, it serves two primary purposes: vasodilation and increasing the renal excretion of sodium and water. The understanding of ANP’s role in cardiac systems has improved considerably in recent decades. This review focuses on several studies demonstrating the importance of analyzing the regulations between the endocrine and mechanical function of the heart and emphasizes the effect of ANP, as the primary hormone of the atria, on atrial fibrillation (AF) and related diseases. The review first discusses the available data on the diagnostic and therapeutic applications of ANP and then explains effect of ANP on heart failure (HF) and atrial fibrillation (AF) and vice versa, where tracking ANP levels could lead to understanding the pathophysiological mechanisms operating in these diseases. Second, it focuses on conventional treatments for AF, such as cardioversion and catheter ablation, and their effects on cardiac endocrine and mechanical function. Finally, it provides a point of view about the delayed recovery of cardiac mechanical and endocrine function after cardioversion, which can contribute to the occurrence of acute heart failure, and the potential impact of restoration of the sinus rhythm by extensive ablation or surgery in losing ANP-producing sites. Overall, ANP plays a key role in heart failure through its effects on vasodilation and natriuresis, leading to a decrease in the activity of the renin-angiotensin-aldosterone system, but it is crucial to understand the intimate role of ANP in HF and AF to improve their diagnosis and personalizing the patients’ treatment. MDPI 2023-03-30 /pmc/articles/PMC10095038/ /pubmed/37047444 http://dx.doi.org/10.3390/ijms24076470 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Rahbar Kouibaran, Farzad Sabatino, Mario Barozzi, Chiara Diemberger, Igor Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria |
title | Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria |
title_full | Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria |
title_fullStr | Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria |
title_full_unstemmed | Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria |
title_short | Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria |
title_sort | atrial natriuretic peptides as a bridge between atrial fibrillation, heart failure, and amyloidosis of the atria |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095038/ https://www.ncbi.nlm.nih.gov/pubmed/37047444 http://dx.doi.org/10.3390/ijms24076470 |
work_keys_str_mv | AT rahbarkouibaranfarzad atrialnatriureticpeptidesasabridgebetweenatrialfibrillationheartfailureandamyloidosisoftheatria AT sabatinomario atrialnatriureticpeptidesasabridgebetweenatrialfibrillationheartfailureandamyloidosisoftheatria AT barozzichiara atrialnatriureticpeptidesasabridgebetweenatrialfibrillationheartfailureandamyloidosisoftheatria AT diembergerigor atrialnatriureticpeptidesasabridgebetweenatrialfibrillationheartfailureandamyloidosisoftheatria |